UKRG Handbook Radiochemical Purity Systems of Radiopharmaceuticals
Stationary phases:
ITLC-SG Instant thin-layer chromatography, silica gel, Pal Gelman Laboratory
ITLC-SA Instant thin-layer chromatography, silicic acid, Gelman (No longer available)
3MM Whatman 3MM chromatography paper
No 1 Whatman No 1 chromatography paper
silica gel Silica gel 60, e.g. Merck
alumina aluminium oxide, Bakerflex
cellulose cellulose, e.g. Merck
Mobile phases:
butanone = 2-butanone = methyl ethyl ketone = MEK
1 M sodium acetate = 82 mg/mL anhydrous sodium acetate
or 136 mg/mL sodium acetate trihydrate
0.1 M citrate = 21 mg/mL monosodium citrate dihydrate
1 M ammonium acetate = 77 mg/mL ammonium acetate
mixtures of volatile solvents should be made freshly each day
|
Radiopharma-ceutical |
Stationary
phase |
phase |
Rf RH-Tc |
Rf TcO4 |
Rf Tc-bound |
|
99mTc-pertechnetate |
ITLC-SG |
acetone or saline |
0.0 |
1.0 |
- |
|
99mTc-MDP |
ITLC-SG or 3MM |
acetone |
0.0 |
1.0 |
0.0 |
|
99mTc-MDP |
ITLC-SG |
1 M sodium acetate or saline |
0.0 |
1.0 |
1.0 |
|
99mTc-DTPA |
ITLC-SG or 3MM |
Acetone |
0.0 |
1.0 |
0.0 |
|
99mTc-DTPA |
ITLC-SG or 3MM |
saline |
0.0 |
1.0 |
1.0 |
|
99mTc-colloid |
ITLC-SG or 3MM |
acetone or saline |
0.0 |
1.0 |
0.0 |
|
99mTc-DMSA |
3MM |
acetone |
0.0 |
1.0 |
0.0 |
|
99mTc-DMSA |
ITLC-SA |
butanol acidified with 0.3 M HCl |
0.0 |
0.9 |
0.5 |
|
99mTc-MAA |
ITLC-SG or 3MM |
acetone or saline |
0.0 |
1.0 |
0.0 |
|
99mTc-pyrophosphate |
ITLC-SG or 3MM |
acetone |
0.0 |
1.0 |
0.0 |
|
99mTc-pyrophosphate |
ITLC-SG |
water |
0.0 |
1.0 |
1.0 |
|
99mTc-HSA |
ITLC-SG or 3MM |
acetone |
0.0 |
1.0 |
0.0 |
|
99mTc-HSA |
ITLC-SG strip should be pre-saturated with human serum albumin and dried |
ethanol-ammonia-water (2:1:5) |
0.0 |
1.0 |
1.0 |
|
99mTc-HIG |
ITLC-SG or 3MM |
acetone, saline, or 0.1 M citrate |
0.0 |
1.0 |
0.0 |
|
99mTc(V)-DMSA |
ITLC-SG |
butanone |
0.0 |
1.0 |
0.0 |
|
99mTc(V)-DMSA |
ITLC-SG |
saline |
0.0 |
1.0 |
1.0 |
|
99mTc(V)-DMSA |
silica gel |
butanol-acetic acid- water (3:2:3) |
0.0 |
0.8 |
0.5 |
|
99mTc-IDAs |
ITLC-SA |
20% sodium chloride |
0.0 |
1.0 |
0.0 |
|
99mTc-IDAs |
3MM spot must be dry |
butanone |
0.0 |
0.9 |
0.0 |
|
99mTc-IDAs |
ITLC-SG |
water or 50% acetonitrile |
0.0 |
1.0 |
1.0 |
|
99mTc-sestamibi |
Alumina Pre-spot
with ethanol; do not allow spot to dry |
ethanol |
0.0 |
0.0 |
1.0 |
|
99mTc-tetrofosmin |
ITLC-SG spot must
be dry |
acetone-dichloromethane (35:65) |
0.0 |
1.0 |
0.5 |
|
99mTc-MAG3 |
ITLC-SG |
ethyl acetate-butanone (3:2) |
0.0 |
1.0 |
0.0 |
|
99mTc-MAG3 |
ITLC-SG |
50% acetonitrile |
0.0 |
1.0 |
1.0 |
|
99mTc-exametazime |
ITLC-SG |
butanone |
0.0 |
1.0 |
1.0 |
|
99mTc-exametazime |
ITLC-SG |
saline |
0.0 |
1.0 |
0.0 |
|
99mTc-exametazime |
No 1 |
50% acetonitrile |
0.0 |
1.0 |
1.0 |
|
99mTc-sulesmurab
(Leukoscan) |
ITLC-SG or 3MM |
acetone, saline, or 0.1 M citrate |
0.0 |
1.0 |
0.0 |
|
99mTc-depreotide
(Neospect) |
ITLC-SG |
saturated solution of sodium chloride |
0.0 |
1.0 |
0.0 |
|
99mTc-depreotide
(Neospect) |
ITLC-SG |
1 M ammonium acetate-methanol (1:1) |
0.0 |
1.0 |
1.0 |
Substitutions:
in most cases, 2-butanone (methyl ethyl ketone, MEK) can be substituted for acetone
in most cases, water can be substituted for saline
in most cases, Whatman No 1 can be substituted for Whatman 3MM paper
ACD can be substituted for 0.1 M citrate
|
Radiopharma-ceutical |
Stationary phase |
phase |
Rf free |
Rf bound |
|
14C-urea |
cellulose |
butanol-water-acetic acid (12:5:3) |
? |
0.6 |
|
123/131I-hippuran |
silica gel |
chloroform-acetic acid (9:1) |
0.0 |
0.2-0.3 |
|
123/131I-MIBG |
silica gel |
ethyl acetate-ethanol (1:1) |
0.6 |
0.0 |
|
111In-DTPA |
ITLC-SG |
10% ammonium acetate- methanol (1:1) |
0.1 |
1.0 |
|
111In-octreotide |
ITLC-SG |
0.1 M citrate buffer pH 5 |
1.0 |
0.0 |
|
18F-FDG |
silica gel |
acetonitrile-water (95:5) |
0.0 |
0.6 |
|
123I-
ioflupane |
ITLC-SG spot must be dry |
chloroform-methanol (9:1) |
0.0 |
1.0 |
|
123I-iomazenil |
silica gel |
ethyl acetate-ammonium hydroxide (200:1) |
0.0 |
0.7 |
|
123I-iomazenil |
silica gel |
chloroform-acetic acid- water (65:35:5) |
0.0 |
0.3 |
|
131I-iodocholesterol |
silica gel |
chloroform-ethanol (1:1) |
0.0 |
0.66 |
Solid-phase extraction cartridge methods (e.g. Sep-Pak)
General procedure:
1. Pre-wet (“activate”) cartridge with 2-5 mL ethanol or methanol.
2. Prepare cartridge with 2-10 mL of preparation solvent.
3. Place a drop of the radiopharmaceutical in the inlet of the cartridge.
4. Elute sequentially with 2-10 mL quantities of eluates A, B, C and collect each in a separate tube; after the last eluate, force air through the cartridge to dry it.
5. Place the cartridge in another tube for measurement of residual activity.
6. Measure the activity in each tube in an ionisation chamber.
7. Calculate radiochemical purity as per table.
|
Radiopharma-ceutical |
Type
of cartridge |
Prepar-ation solvent |
A |
B |
C |
D |
Purity |
|
99mTc-sestamibi |
alumina N |
0.5 mL ethanol |
10 mL ethanol |
cartridge residue |
|
|
A/total |
|
99mTc- sestamibi |
C18 |
2 mL saline |
2 mL saline |
5 mL ethanol |
cartridge residue |
|
B/total |
|
99mTc- tetrofosmin |
C18 |
2 mL saline |
2 mL saline |
5 mL ethanol |
cartridge residue |
|
B/total |
|
99mTc- tetrofosmin |
silica |
5 mL saline then 1 mL air
|
10 mL methanol-water (70:30) over 2 minutes | cartridge residue | B/total | ||
|
99mTc- tetrofosmin |
silica |
5 mL saline then 1 mL air
|
10 mL methanol-water (70:30) over 2 minutes | 10 mL methanol-saline (80:20) | cartridge residue | B/total | |
|
99mTc-MAG3 |
C18 |
10 mL 1 mM HCl |
10 mL 1 mM HCl |
10 mL 50% ethanol |
cartridge residue |
|
B/total |
|
99mTc-MAG3 |
C18 |
10 mL 1 mM HCl |
5 mL 1 mM HCl |
5 mL 0.5% ethanol in PB |
10 mL 7% ethanol in PB |
cartridge residue |
C/total |
|
99mTc-exametazime |
C18 |
5 mL saline |
5 mL saline |
cartridge residue |
|
|
B/total |
|
99mTc-exametazime |
C18 |
5 mL saline |
5 mL saline |
5 mL ethanol |
cartridge residue |
|
B/total |
|
111In- octreotide |
C18 |
10 mL water |
5 mL water |
5 mL methanol |
cartridge residue |
|
B/total |
|
123I-ioflupane |
C18 |
5 mL water |
5 mL water |
5 mL ethanol |
cartridge residue |
|
B/total |
|
123/131I-MIBG |
C18 |
5 mL water |
5 mL water |
10 mL PB-THF (3:1) |
cartridge residue |
|
B/total |
|
123/131I-MIBG |
C18 |
5 mL water |
5 mL 10 mM NaOH |
cartridge residue |
|
|
B/total |
Preparation of reagents:
1 mM HCl (0.001 M HCl) = 1 mL conc HCl per litre of distilled water.
PB for MAG3 = 0.01 M (10 mM) sodium phosphate buffer pH 6
Prepare 100 mL 0.01 M monosodium phosphate solution (NaH2PO4). Prepare 20 mL 0.01 M disodium phosphate solution (Na2HPO4). Add 10 mL disodium phosephate solution to 100 mL monosodium phosphate solution. pH should still be below 6. Add disodium phosphate solution dropwise until pH of 6 is obtained.
PB for MIBG = 0.1 M (100 mM) monosodium phosphate (NaH2PO4)
THF = tetrahydrofuran
10 mM NaOH (0.01 M NaOH) = 0.4 g dissolved in 1 litre of distilled water
or dilute 1 mL 1 M NaOH with 99 mL distilled water
Cartridges can be re-used after decay of radioactivity
| 1. Prepare a 10 ml test
tube containing 3 ml of ethyl acetate and 3 ml of 0.9% w/v sodium chloride
solution. 2 Add several drops of 99mTc-exametazime (immediately after reconstitution). 3 Cap the tube and mix on a vortex mixer for 1 min. 4 Allow the tube to stand for 1 min to allow the two phases to separate. 5 Remove the top layer using a pipette into another test tube. 6 Measure the activities in each layer. 7 Calculate the % lipophilic complex as follows:- % Primary complex = Activity in the ethyl acetate layer x 100 (should be greater than 80 %) Total activity in both layers |